Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Daniel J Berlau"'
Publikováno v:
Translational Neurodegeneration, Vol 7, Iss 1, Pp 1-11 (2018)
Abstract Nearly 30% of adults 40 years and older in the United States are on a statin. Their widespread use heightens the importance of careful consideration of their varied effects on the body. Although randomized controlled trials have not confirme
Externí odkaz:
https://doaj.org/article/61ae1075d92b419b8ecbd813689a206d
Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology
Publikováno v:
Best Practice & Research Clinical Obstetrics & Gynaecology. 85:59-67
There is a growing body of evidence that cannabis may be effective as an analgesic with potential to reduce opioid usage in chronic pain. This review synthesizes the available literature to elucidate the possible role that cannabis might play in redu
Publikováno v:
Expert opinion on pharmacotherapy. 23(15)
Duchenne muscular dystrophy (DMD) is a progressive genetic disease characterized by muscular weakness with a global prevalence of 7.1 cases per 100,000 males. DMD is caused by mutations of the dystrophin gene on the X chromosome, which is responsible
Publikováno v:
J Pediatr Pharmacol Ther
Melatonin manufacturers in the United States have begun producing melatonin products specifically targeted for use in the pediatric population. This paper aims to critically evaluate the evidence available regarding the use of melatonin in children b
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 79(17)
Purpose The objective of this review is to detail the utility of statin medications in the prevention and treatment of intensive care unit (ICU) delirium. Summary Delirium is a syndrome characterized by altered mental status, inattention, and disorga
Publikováno v:
Complementary Therapies in Medicine. 42:151-155
Attention deficit/hyperactivity disorder (ADHD) is a condition that affects many children and adults throughout the world. ADHD symptoms have been associated with changes in catecholamine release. Current therapies for ADHD have a variety of limitati
Publikováno v:
Expert opinion on pharmacotherapy. 21(7)
Duchenne muscular dystrophy (DMD) is the result of X-chromosome-linked mutations to the dystrophin protein gene that prevent the normal development and repair of muscles leading to muscle deterioration. The condition affects nearly 1 in 3,500 males w
Publikováno v:
Future Neurology. 12:79-88
Traumatic brain injury results in significant morbidity and mortality, and there is an urgent need for neuroprotective medications that can prevent the persisting symptoms and disabilities following injury. Several existing pharmacotherapies have bee
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:492-499
Duchenne muscular dystrophy (DMD) is a genetic neuromuscular disease that primarily affects young males. Patients with DMD are unable to produce dystrophin, a crucial protein found in myocytes, leading to a loss of muscle support and integrity. Corti
Publikováno v:
Pain management. 9(2)
With the opioid epidemic reaching new heights in the USA, it has become critical to find suitable alternatives to opioids. Cannabis, an antinociceptive, is a strong contender to help patients reduce their opioid usage. A growing literature has been e